Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors - Deken, M.A.; Niewola-Staszkowska, K.; Peyruchaud, O.; Mikulčić, N.; Antolić, M.; Shah, P.; Cheasty, A.; Tagliavini, A.; Nizzardo, A.; Pergher, M.; Ziviani, L.; Milleri, S.; et al. (Immuno-oncology technology, 2023)
Keywords: autotaxin (ATX); immuno-oncology; inhibitor; Life Sciences; lysophosphatidic acid (LPA); Original; stroma; autotaxin (ATX); immuno-oncology; inhibitor; lysophosphatidic acid (LPA); stroma